Please enable Javascript
24th Congress of the European Hematology Association
Phase III Trial: Use of Venetoclax with Bortezomib/Dexamethasone in Treating Multiple Myelome
DocWire News Editors
European Society of Hematology 2019
|
April 7, 2023
Recent research shows that a biomarker-driven approach to treating multiple myeloma patients with venetoclax may be best ...
Breaking News from EHA 2019 in Amsterdam
DocWire News Editors
European Society of Hematology 2019
|
June 20, 2019
Check out the latest news from the 24th Congress of the European Hematology Association. ...
Targeting NADK Holds Promise in Treating NOTCH1-Driven T-Cell Acute Lymphoblastic Leukemia
DocWire News Editors
European Society of Hematology 2019
|
June 20, 2019
Research presented at the 24th Congress of the European Hematology Association (EHA) found that potent inhibitors of ...
EHA: Addition of Daratumumab to Standard of Care Improves Response in Newly Diagnosed Myeloma
Kerri Fitzgerald
European Society of Hematology 2019
|
July 5, 2023
Research presented at the European Hematology Association 24th Congress found that the addition of daratumumab to ...
EHA: Voxelotor for Sickle Cell Disease Has Disease-Modifying Potential
Kerri Fitzgerald
European Society of Hematology 2019
|
August 29, 2023
European Hematology Association 24th Congress found that voxelotor significantly increased hemoglobin levels and reduced ...
Study Finds Gene Therapy Effective in Treating Thalassemia
DocWire News Editors
European Society of Hematology 2019
|
August 31, 2023
Research presented last week at the 24th Congress of European Hematology Association (EHA) in Amsterdam found gene ...
Success of Venetoclax and Obinutuzumab Use in Patients with CLL
DocWire News Editors
European Society of Hematology 2019
|
June 14, 2019
Research presented by Dr. Kirsten Fischer at the 24th Congress of European Hematology Association (EHA) in Amsterdam on ...
Study Finds Women With Rare Bone Marrow Cancer Can Still Have Safe Childbirth
DocWire News Editors
European Society of Hematology 2019
|
June 14, 2019
A new study presented by Dr. Ekaterina Chelysheva at the 24th Congress of European Hematology Association (EHA) in ...
Advertisement
Advertisement
Advertisement
Advertisement